Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 19, 2021.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
The American Academy of Neurology has issued a new clinical practice guideline with recommendations for the treatment of motor symptoms in early Parkinson disease (PD) this week. This new guidance updates an existing practice guideline published in 2002 that outlines initiation of treatment for early PD and use of dopaminergic medications.
The postdoctoral scholar at the University of Iowa commented on why the multiple sclerosis field should lean on registered dietitians to help alleviate symptoms of patients with multiple sclerosis. Titcomb provides his thoughts on the role RDs and nutritionists play in the care of patients with MS. He cited what has been previously observed in the literature and why there needs to be an increased effort within the research.
The director of the Comprehensive Epilepsy Center at NYU Langone discussed his recently published research, which identified a novel biomarker for sudden unexpected death in epilepsy. Additionally, he shared why the results carry so much weight clinically, and provided insight on what has been previously observed in terms of SUDEP biomarkers.
In episode 2 of this NeurologyLive® Insights series, "Expert Perspectives on the Management of Acute and Preventative Migraine," David Kudrow, MD, explains how to decide on migraine treatment with a patient and when to consider preventive treatment options.
Mind Moments™, a podcast from NeurologyLive®, brings you an exclusive interview with Karl Doghramji, MD, FAASM, DFAPA, in which he shares his perspective on the current state of care for sleep disorders, the impact of the pandemic on sleep in the US, and some of the recent advances in therapeutics and research.
Recognize and celebrate the individuals who have achieved landmark successes within multiple sclerosis! Giants of Multiple Sclerosis™ is a premier neuroscience award that celebrates pioneers, innovators, and future generations of leaders who have been selected by their peers for their remarkable achievements in Multiple Sclerosis.
Nominate Someone Today for a 2022 Giants of Multiple Sclerosis™ Award